Refractory ascites
Showing 1 - 25 of 9,336
Point-of-Care Echocardiography to Assess Impact of Dynamic
Recruiting
- Cirrhosis, Liver
- +4 more
- Echocardiographic assessment
-
Chandigarh, Delhi, IndiaPGIMER
Jan 17, 2023
QOL and Sarcopenia in Patients With Ascites
Not yet recruiting
- Ascites Hepatic
- Ascites, Malignant
- Quality of Life surveys
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine
Feb 10, 2023
Ascites Hepatic Trial in Alexandria (Empagliflozin 10 MG, Diuretics)
Recruiting
- Ascites Hepatic
- Empagliflozin 10 MG
- Diuretics
-
Alexandria, EgyptAlexandria University
Jun 18, 2022
Liver Cirrhosis, Cirrhosis, Ascites Trial in Redwood City (Empagliflozin 10 MG)
Recruiting
- Liver Cirrhosis
- +4 more
- Empagliflozin 10 MG
-
Redwood City, CaliforniaStanford University Digestive Health Clinic
Mar 21, 2022
Ascites, Paracentesis, Cirrhosis Trial in France (Alphapump, Ascites puncture)
Recruiting
- Ascites
- +2 more
- Alphapump
- Ascites puncture
-
Amiens, France
- +8 more
Jun 9, 2022
Refractory Ascites in Children With Cirrhosis Trial in New Delhi (Midodrine, Standard medical treatment)
Recruiting
- Refractory Ascites in Children With Cirrhosis
- Midodrine
- Standard medical treatment
-
New Delhi, IndiaILBS
Nov 11, 2021
Hepatic Encephalopathy, Cirrhosis, Liver Trial in Chicago (HepQuant)
Withdrawn
- Hepatic Encephalopathy
- Cirrhosis, Liver
- HepQuant
-
Chicago, IllinoisNorthwestern University
Aug 5, 2022
Refractory Malignant Ascites Trial in Shanghai (Oncorine (H101))
Recruiting
- Refractory Malignant Ascites
- Oncorine (H101)
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Refractory Malignant Ascites Trial in Shanghai (H101, Tislelizumab)
Recruiting
- Refractory Malignant Ascites
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 2, 2022
Liver Cirrhosis Trial in New Delhi (drug, biological, other)
Recruiting
- Liver Cirrhosis
- Midodrine
- +3 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jun 12, 2021
Point-of-Care Echocardiography to Assess Impact of Dynamic
Recruiting
- Hepatorenal Syndrome
- +4 more
- Echocardiographic assessment
-
Chandigarh, Delhi, IndiaPGIMER
Jun 21, 2022
Cirrhosis, Ascites Hepatic Trial in Richmond (Terlipressin acetate continuous infusion)
Completed
- Cirrhosis
- Ascites Hepatic
- Terlipressin acetate continuous infusion
-
Richmond, VirginiaHunter Holmes McGuire VA Medical Center
Jun 22, 2021
Liver Cirrhosis, Ascites Trial in Winnipeg (device, procedure, biological)
Completed
- Liver Cirrhosis
- Ascites
- Peritoneal Dialysis Catheter
- +3 more
-
Winnipeg, Manitoba, CanadaHealth Sciences Centre
Apr 19, 2021
Management of Malignant Ascites by Interventional Radiology
Withdrawn
- Refractory Malignant Ascites
- Paracentesis
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 11, 2022
Liver Diseases, Portal Hypertension, Cirrhosis, Liver Trial (Transjugular intrahepatic portosystemic shunt (TIPS), microwave
Not yet recruiting
- Liver Diseases
- +4 more
- Transjugular intrahepatic portosystemic shunt (TIPS)
- microwave ablation (MWA)
- (no location specified)
Dec 17, 2020
Pleural Effusion, Malignant Trial (IFN-? and CIK cells, Tcm cells or CAR T cells)
Not yet recruiting
- Pleural Effusion, Malignant
- IFN-γ and CIK cells, Tcm cells or CAR T cells
- (no location specified)
Mar 16, 2022
Ascites Hepatic Trial (PleurX catheter)
Completed
- Ascites Hepatic
- PleurX catheter
- (no location specified)
Sep 24, 2020
Refractory Ascites, Children, Only Trial in Shibin Al Kawm (Midodrine 2.5 mg tab)
Unknown status
- Refractory Ascites
- Children, Only
- Midodrine 2.5 mg tab
-
Shibīn Al Kawm, Menofiya, EgyptPediatric Hepatology, Gastroenterology and Nutrition Department,
Aug 20, 2020
Liver Cirrhoses, Malignant Ascites Trial in Leipzig, Bern (Alfapump)
Recruiting
- Liver Cirrhoses
- Malignant Ascites
- Alfapump
-
Leipzig, Germany
- +1 more
Oct 23, 2020
Liver Cirrhosis, Refractory Ascites, Malignant Ascites Trial in Worldwide
Completed
- Liver Cirrhosis
- +2 more
-
Dresden, Germany
- +12 more
Oct 23, 2020
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites Trial in United States (BAX69 Single-Route Arm, BAX69
Terminated
- Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
- BAX69 Single-Route Arm
- BAX69 Double-Route Arm
-
Miami, Florida
- +5 more
Dec 22, 2020
Ascites Trial in New York (McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of
Completed
- Ascites
- McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 5, 2020